comparemela.com

Latest Breaking News On - Usfda warning letter - Page 1 : comparemela.com

Cipla faces downgrade after USFDA warning letter

B&K Securities airs concerns considering Cipla’s significant exposure to the US market, constituting 28% of consolidated sales

Cipla slumps nearly 8% after USFDA warning letter for manufacturing lapses

After an inspection at the Pithampur plant, the USFDA issued a warning letter stating that the company s methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to good manufacturing practices, and that its drug products are adulterated.

vimarsana © 2020. All Rights Reserved.